Variables influencing pregnancy termination following prenatal diagnosis of fetal chromosome abnormalities

Journal of Genetic Counseling

Volumn 22, Issue 2, 2013, Pages 238-248

  Hawkins, Anne ^a,b   Stenzel, Ana ^a   Taylor, Joanne ^a   Chock, Valerie Y ^a   Hudgins, Louanne ^a  

^a STANFORD UNIVERSITY   (United States)

^b Perinatal Diagnostic Center at Salinas   (United States)

Author keywords

Abortion; Cell free fetal DNA; cffDNA; Characteristics; Chromosome abnormality; Down syndrome; Noninvasive testing; Pregnancy termination; Prenatal diagnosis; Variables

Indexed keywords

CHROMOSOME ABERRATION; FEMALE; HUMAN; INDUCED ABORTION; PREGNANCY; PRENATAL DIAGNOSIS; ARTICLE;

ABORTION, INDUCED; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84878523475     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-012-9539-1     Document Type: Article

References (42)

1. Ahmed, S.; Hewson, J.; Green, J.; Cuckle, H.; Hirst, J.; & Thornton, J. (2008). Decisions about testing and termination of pregnancy for different fetal conditions: a qualitative study of European white and Pakistani mothers of affected children. Journal of Genetic Counseling, 17, 560-572.
2. Ashoor, G.; Argyro Syngelaki, R. M.; Wagner, M.; Birdie, C.; & Nicolaides, K. (2012). Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy and trisomy 18. American Journal of Obstetrics and Gynecology, 206(322), 1-5.
3. Balkan, M.; Kalkanli, S.; Akbas, H.; Yalinkaya, A.; Alp, M. N.; & Budak, T. (2010). Parental decisions regarding a prenatally detected fetal chromosomal abnormality and the impact of genetic counseling: an analysis of 38 cases with aneuploidy in Southeast Turkey. Journal of Genetic Counseling, 19(3), 241-246. PubMed PMID: 20119701.
4. Benn, P. A.; & Chapman, A. R. (2010). Ethical challenges in providing non-invasive prenatal diagnosis. Current Opinion in Obstetrics and Gynecology, 22, 128-134.
5. Bianchi, D.; Platt, L.; Goldberg, J.; Abuhamad, A.; Sehnert, A.; & Rava, R. (2012). Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstetrics and Gynecology, 119(5), 890-901.
6. Britt, D.; Risinger, S.; Miller, V.; Mans, M.; Krivchenia, E.; & Evans, M. (2000). Determinants of parental decisions after the prenatal diagnosis of Down syndrome: bringing in context. American Journal of Medical Genetics, 93(5), 410-416.
7. Brun, J.-L.; Gangbo, F.; Wen, Z.; Galant, K.; Taine, L.; Maugey-Laulom, B.; et al. (2004). Prenatal diagnosis and management of sex-chromosome aneuploidy: a report on 98 cases. Prenatal Diagnosis, 24, 213-218.
8. Chiu, W.; Akolekar, R.; Zheng, Y.; Leung, T.; Sun, H.; Chan, K. C.; et al. (2011). Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: a large scale validity study. British Medical Journal, 342, c7401.
9. Choi, H.; Van Riper, M.; & Thoyre, S. (2012). Decision making following a prenatal diagnosis of Down syndrome: an integrative review. Journal of Midwifery Women's Health, 57(2), 156-164.
10. De Jong, A.; Dondorp, W.; Frints, S.; de Die-Smulders, C.; & de Wert, G. (2011). Advances in prenatal screening: the ethical dimension. Nature Reviews Genetics, 2, 657-663.
11. Devers, P.; Ormond, K.; Facio, F.; & Brasington, C. (2012). Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. [NSGC Position Statement, adopted February 18, 2012]. Retrieved from http://www.nsgc.org/Portals/0/Advocacy/ NSGC%20Noninvasive%20Prenatal%20Testing%204-17-2012.pdf.
12. Drugan, A.; Greb, A.; Johnson, M. P.; Krivchenia, E.; Uhlmann, W.; Moghissi, K.; et al. (1990). Determinants of parental decisions to abort for chromosome abnormalities. Prenatal Diagnosis, 10(8), 483-490. PubMed PMID: 2267225.
13. Evans, M.; Sobiecki, M.; Krivchenia, E.; Duquette, D.; Drugan, A.; Hume, R.; et al. (1996). Parental decisions to terminate/continue following abnormal cytogenetic prenatal diagnosis: "what" is still more important than "when". American Journal of Medical Genetics, 61(4), 353-355.
14. Hall, A.; Bostanci, A.; & Wright, C. F. (2010). Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Public Health Genomics, 13, 246-255.
15. Hamamy, H.; & Dahoun, S. (2003). Parental decisions following the prenatal diagnosis of sex chromosome abnormalities. European Journal of Obstetrics and Gynecology, 116, 58-62.
16. Holmes-Siedle, M.; Ryynanen, M.; & Lindenbaum, R. H. (1987). Parental decisions regarding termination of pregnancy following prenatal detection of sex chromosome abnormality. Prenatal Diagnosis, 7(4), 239-244.
17. ISPD Position Statement. (2011). Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011. Prenatal Diagnosis, 31, 519-522.
18. Kobelka, C.; Mattman, A.; & Langlois, S. (2009). An evaluation of the decision-making process regarding amniocentesis following a screen-positive maternal serum screen result. Prenatal Diagnosis, 29, 514-519.
19. Korenromp, M.; Page-Chrisiaens, G.; van den Bout, J.; Mulder, E.; & Visser, G. (2007). Maternal decision to terminate pregnancy after diagnosis of Down syndrome. American Journal of Obstetrics and Gynecology, 196(2), 149.e1-149e.11.
20. Kramer, R.; Jarve, R.; Yaron, Y.; Johnson, M.; Lampinen, J.; Kasperski, S.; et al. (1998). Determinants of parental decisions after prenatal diagnosis of Down syndrome. American Journal of Medical Genetics, 79, 172-174.
21. Kupperman, M.; Learman, L.; Gates, E.; Gregorich, S.; Nease, R.; Lewis, J.; et al. (2006). Beyond race or ethnicity and socioeconomic status: predictors of prenatal testing for Down syndrome. Obstetrics and Gynecology, 107(5), 1087-1097.
22. Malone, F. D.; Canick, J. A.; Ball, R. H.; Nyberg, D. A.; Comstock, C. H.; Bukowski, R.; Berkowitz, R.; et al. (2005). First trimester or second-trimester screening, or both, for Down's syndrome. The New England Journal of Medicine, 353(19), 2001-2011.
23. Mansfield, C.; Hopfer, S.; & Marteau, T. M. (1999). Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and turner and Klinefelter syndromes: a systemic literature review. Prenatal Diagnosis, 19, 808-812.
24. Mezei, G.; Papp, C.; Toth-Pal, E.; Beke, A.; & Papp, Z. (2004). Factors influencing parental decision making in prenatal diagnosis of sex chromosome aneuploidy. Obstetrics and Gynecology, 104, 94-101.
25. Morris, J.; & Alberman, E. (2009). Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down syndrome Cytogenetic Register. British Medical Journal, 339, b3794.
26. Natoli, J.; Ackerman, D.; McDermott, S.; & Edwards, J. (2012). Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995-2011). Prenatal Diagnosis, 32, 142-153.
27. Newson, A. (2008). Ethical aspects arising from non-invasive fetal diagnosis. Seminars in Fetal and Neonatal Medicine, 13(2), 103-108.
28. Palomaki, G.; Kloza, E.; Lambert-Messerlian, G.; Haddow, J.; Neveux, L.; Ehrich, M.; et al. (2011). DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genetics in Medicine, 13(11), 913-920.
29. Palomaki, G.; Deciu, C.; Kloza, E.; Lambert-Messerlian, G.; Haddow, J.; Neveux, L.; et al. (2012). DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genetics in Medicine, 14(3), 296-305.
30. Perry, S.; Woodall, A.; & Pressman, E. (2007). Association of ultrasound findings with decision to continue Down syndrome pregnancies. Community Genetics, 10, 227-230.
31. Press, N.; & Browner, C. (1997) Why women say yes to prenatal diagnosis. Social Science & Medicine, 45(7), 979-989.
32. Pryde, P.; Drugan, A.; Johnson, M. P.; Isada, N. B.; & Evans, M. (1993). Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results. Clinical Obstetrics and Gynecology, 36(3), 496-509.
33. Quadrelli, R.; Quadrelli, A.; Mechoso, B.; Laufner, M.; Jaumandreu, C.; & Vaglio, A. (2007). Parental decisions to abort or continue a pregnancy following prenatal diagnosis of chromosomal abnormalities in a setting where termination of pregnancy is not legally available. Prenatal Diagnosis, 27, 228-232.
34. Schechtman, K.; Gray, D.; Baty, J.; & Rothman, S. (2002). Decision-making for termination of pregnancies with fetal anomalies: analysis of 53,000 pregnancies. Obstetrics and Gynecology, 99(2).
35. Seror, V.; & Ville, Y. (2010). Women's attitudes to the successive decisions possibly involved in prenatal screening for Down syndrome: how consistent with their actual decisions? Prenatal Diagnosis, 30, 1086-1093.
36. Shaffer, B.; Caughey, A.; & Norton, M. (2006). Variation in the decision to terminate pregnancy in the setting of fetal aneuploidy. Prenatal Diagnosis, 26(8), 667-671.
37. Skotko, B. (2009). With new prenatal testing, will babies with Down syndrome slowly disappear? Archives of Disease in Childhood, 94(11), 823-826.
38. Sparks, A.; Wang, E.; Struble, C.; Barrett, W.; Stokowski, R.; McBride, C.; et al. (2010). Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenatal Diagnosis, 32, 3-9.
39. Verp, M.; Bombard, A.; Simpson, J.; & Elias, S. (1988). Parental decision following prenatal diagnosis of fetal chromosome abnormality. American Journal of Medical Genetics, 29(3), 613-622.
40. Zamerowski, S.; Lumley, M.; Arreola, R.; Dukes, K.; & Sullivan, L. (2001). Favorable attitudes toward testing for chromosomal abnormalities via analysis of fetal cells in maternal blood. Genetics in Medicine, 3(4), 301-309.
41. Zlotogora, J. (2002). Parental decisions to abort or continue a pregnancy with an abnormal finding after an invasive prenatal test. Prenatal Diagnosis, 22, 1102-1106.
42. Zyblewski, S.; Hill, E.; Shirali, G.; Atz, A.; Forbus, G.; Gonzalez, J.; et al. (2009). Chromosomal anomalies influence parental treatment decisions in relation to prenatally diagnosed congenital heart disease. Pediatric Cardiology, 30, 1105-1111.